Genome Medical Announces Closing of $60 Million Series C Financing

30 Aug, 2021

Genome Medical Announces Closing of $60 Million Series C Financing
Photo by Goran Ivos on Unsplash

– Genome Medical, the leading nationwide genomic care delivery company, announced the closing of a $60m Series C financing to accelerate commercial traction and advance its mission of transforming health care for all through genomic medicine.
– These strategic initiatives solidify its position as the preeminent technology-enabled provider of genetic health services and genomic insights.
– Genome Medical will use the financing proceeds to expand its team and further enhance the development of its configurable technology solutions to provide innovative and efficient genomic medicine programs.
– The company will continue to build out its full suite of physician services, test ordering capabilities and guidelines-based care plans to ensure comprehensive, seamless care for patients.

Genetics Health Care Life Science Medical North America
Crunchbase icon

Content report

The following text will be sent to our editors: